RC-106, a proteasome inhibitor (IC50: 35 µM) and Sigma receptor modulator, exhibits anticancer activity and antiproliferative effects against cancer cells, including glioblastoma (GB) and multiple myeloma (MM) [1].
Molecular Weight:
355.52
CAS Number:
[1346216-50-9]
Formula:
C26H29N
Target:
Proteasome|||Sigma receptor
T87296
* VAT and and shipping costs not included. Errors and price changes excepted